Everest Medicines Announces Interim Results for First Half of 2025

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/13/2026

1. ORCL
2. ADBE
3. SPY
4. RH
5. CPRT
6. ACVA
7. SEDG
8. QQQ
9. TENB
10. SPCX

Go back to Everest Medicines Announces Interim Results for First Half of 2025
(NASDAQ: IMAB) Delayed: 4.63 --0 (-0%)
Previous Close $4.63    52 Week High $ 
Open $4.63    52 Week Low $ 
Day High $4.63    P/E N/A 
Day Low $4.63    EPS $ 
Volume 19,483